Streetbeat News

Analyst Ratings

SAVA

HC Wainwright & Co. has downgraded Cassava Sciences (NASDAQ:SAVA) from Buy to Neutral, as per analyst Vernon Bernardino.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 11:03 am

VRNA

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on Verona Pharma (NASDAQ:VRNA) and maintained a price target of $36.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 11:01 am

URGN

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on UroGen Pharma (NASDAQ:URGN) and maintained a $60 price target.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:55 am

BIVI

ThinkEquity has initiated coverage on BioVie (NASDAQ:BIVI) with a Buy rating and set a price target of $3.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:52 am

AMZN

Needham analyst Laura Martin reiterates a Buy rating on Amazon.com (NASDAQ:AMZN) and maintains a $205 price target.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:51 am

TSHA

Piper Sandler analyst Christopher Raymond maintains an Overweight rating on Taysha Gene Therapies (NASDAQ:TSHA) but lowers the price target from $9 to $7.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:51 am

AAPL

Needham analyst Laura Martin reiterates a Buy rating on Apple (NASDAQ:AAPL) and maintains a $220 price target.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:49 am

ELAN

Piper Sandler analyst David Westenberg maintains a Neutral rating on Elanco Animal Health (NYSE:ELAN) and lowers the price target from $19 to $16.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:49 am

META

Needham analyst Laura Martin has reiterated an Underperform rating on Meta Platforms (NASDAQ:META).

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:46 am

MLTX

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on MoonLake (NASDAQ:MLTX) and maintained a $100 price target.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 10:41 am